Analystreport

Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Oppenheimer Holdings Inc. from $29.00 to $30.00. They now have an "outperform" rating on the stock.

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com